|
|
|
|
Hookipa Pharma inc (NASDAQ: HOOK) |
|
|
|
| |
HOOK's Net Income Growth by Quarter and Year
Hookipa Pharma Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| HOOK Net Income (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-24.95
|
-24.82
|
-12.31
|
-27.69
|
| III Quarter |
September |
-13.84
|
-19.07
|
-18.28
|
-17.15
|
| II Quarter |
June |
-19.10
|
-18.02
|
-16.36
|
-17.24
|
| I Quarter |
March |
14.38
|
-19.68
|
-17.97
|
-12.48
|
| FY |
|
-43.51
|
-81.59
|
-64.92
|
-74.56
|
| HOOK Net Income fourth quarter 2024 Y/Y Growth Comment |
Hookipa Pharma inc in the fourth quarter 2024 recorded net loss of $ -24.95 millions.
According to the results reported in the fourth quarter 2024, Hookipa Pharma Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Hookipa Pharma Inc ' s Net Income no change of % ranks overall at the positon no. in the fourth quarter 2024.
|
| HOOK Net Income ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
- |
- |
- |
- |
| II Quarter |
June |
- |
- |
- |
- |
| I Quarter |
March |
- |
- |
- |
- |
| FY |
|
- |
- |
- |
- |
HOOK Net Income (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
- |
- |
- |
- |
| II Quarter |
June |
- |
- |
- |
- |
| I Quarter |
March |
- |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
- |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
| Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Hookipa Pharma Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| HOOK's IV. Quarter Q/Q Net Income Comment |
Current net loss of -24.95 millions by Hookipa Pharma inc look even worse compare to the net loss -13.84 millions in the previous quarter.
Within Major Pharmaceutical Preparations industry Hookipa Pharma inc achieved highest sequential Net Income growth. While Hookipa Pharma Inc 's Net Income growth quarter on quarter, overall rank is . |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| HOOK's IV. Quarter Q/Q Net Income Comment |
IV. Quarter 2024 results of -24.95 millions by Hookipa Pharma inc look even worse considering the -13.84 millions a quarter before.
Within Major Pharmaceutical Preparations industry Hookipa Pharma inc achieved highest sequential Net Income growth. While Hookipa Pharma Inc 's Net Income growth quarter on quarter, overall rank is . |
|
Hookipa Pharma Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Dec 31 2024) |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
| Cumulative Net Income 12 Months Ending |
$ -43.50 |
$ -43.37 |
$ -48.60 |
$ -47.52 |
$ -81.58 |
| Y / Y Net Income Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Net Income Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential Net Income Change (TTM) |
- |
- |
- |
- |
- |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# |
# |
# |
# |
# |
| Cumulative Net Income growth
Comment |
Hookipa Pharma inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
|
| Cumulative Net Income growth
Comment |
Hookipa Pharma inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
| Companies with similar Net Income no change for the quarter ending Dec 31 2024 within Healthcare Sector | Y/Y Change % | Net Income for the quarter ending Dec 31 2024 | | Chemed Corporation |  0.30% | $ 0.295 millions |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
